Akshay K. Vaishnaw, M.D., Ph.D.

Akshay K. Vaishnaw, M.D., Ph.D.

Former PresidentatAlnylam Pharmaceuticals· In proxies 2021–2023

Pay in FY2023-8% from the year before · Alnylam Pharmaceuticals stock -19.5% the same year

Akshay K. Vaishnaw, M.D., Ph.D. was paid $3.3M in FY2023 (Dec), down 8%. Alnylam Pharmaceuticals stock fell 19.5% that year.

Pay$100 in the stock at the end of FY20 → $147
Pay is from the Summary Compensation Table of each Alnylam Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Alnylam PharmaceuticalsPublic company · 5 yr
    • Former President2021 – Present · 5 yrStock in role +69%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?